Your search for major depressive disorder returned 16 results

A team of researchers sought to investigate the bidirectional relationship between multiple sclerosis and major depressive disorder with Mendelian randomization.

Proinflammatory cytokines, tryptophan catabolites, and the gut-brain axis may have key roles in chronic fatigue and depression in patients with multiple sclerosis.

What is the link between multiple sclerosis and depression, and how can you help patients with their mental health?

Investigators analyzed the clinical, psychological, and cognitive factors that affect perceived and cognitive performance fatigability in patients with multiple sclerosis.

Hippocampal DVR was strongly correlated with the Beck’s Depression Inventory score in patients with MS.

First symptoms and disease type are contributors to delays in multiple sclerosis diagnosis.

Disease course, fatigue, self-efficacy, and diet and exercise are major determinants of unemployment for patients with MS.

More robust studies suggest that the prevalence of olfactory dysfunction is significant, ranging from 20% to 45% in the MS population.

Researchers sought understand the genetic predisposition and environmental factors on monozygotic twin pairs discordant for MS.

Investigators examine the role of physical activity and exercise in the modification of vascular comorbidities and risk factors in individuals with multiple sclerosis.

The impact of treatment with dimethyl fumarate and fingolimod on lymphocyte and leukocyte count was evaluated in patients with multiple sclerosis.

In a retrospective study, researchers determined whether the COVID-19 pandemic and COVID-19 infection affects disease course in patients with MS.

Researchers sought to assess the impact of early vs late initiation of natalizumab by looking at clinical and imaging information of patients with MS.

Polyneuropathies occurring in multiple sclerosis contribute to neurological disability.

In a prospective cohort study, researchers assessed whether adverse childhood experiences may increase the risk for multiple sclerosis in women.

Investigators conducted a survey to assess the incidence of COVID-19 in patients with multiple sclerosis as well as the influence of their comorbidities and treatments on outcomes.